Crystalline silica activates the T-cell and the B-cell antigen receptor complexes and induces T-cell and B-cell proliferation

References

• De Vuyst P, Camus P. The past and present of pneumoconioses. Curr Opin Pulm Med. 2000;6:151–156.
   PubMedGoogle Scholar
• Pollard KM. Silica, silicosis, and autoimmunity. Front Immunol. 2016;7:97.
   PubMed Web of Science ®Google Scholar
• Lee S, Hayashi H, Mastuzaki H, et al. Silicosis and autoimmunity. Curr Opin Allergy Clin Immunol. 2017;17:78–84.
   PubMed Web of Science ®Google Scholar
• Caplan A. Certain unusual radiological appearances in the chest of coal-miners suffering from rheumatoid arthritis. Thorax. 1953;8:29–37.
   PubMed Web of Science ®Google Scholar
• Stolt P, Kallberg H, Lundberg I, et al. Silica exposure is associated with increased risk of developing rheumatoid arthritis: results from the Swedish EIRA study. Ann Rheum Dis. 2005;64:582–586.
   PubMed Web of Science ®Google Scholar
• Makol A, Reilly MJ, Rosenman KD. Prevalence of connective tissue disease in silicosis (1985–2006)- a report from the state of Michigan surveillance system for silicosis. Am J Ind Med. 2011;54:255–262.
   PubMed Web of Science ®Google Scholar
• Erasmus LD. Scleroderma in goldminers on the Witwatersrand with particular reference to pulmonary manifestations. S Afr J Lab Clin Med. 1957;3:209–231.
   PubMedGoogle Scholar
• McCormic ZD, Khuder SS, Aryal BK, et al. Occupational silica exposure as a risk factor for scleroderma: a meta-analysis. Int Arch Occup Environ Health. 2010;83:763–769.
   PubMed Web of Science ®Google Scholar
• Parks CG, Cooper GS, Nylander-French LA, et al. Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum. 2002;46:1840–1850.
   PubMed Web of Science ®Google Scholar
• Hogan SL, Cooper GS, Savitz DA, et al. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol. 2007;2:290–299.
   PubMed Web of Science ®Google Scholar
• Lippmann M, Eckert HL, Hahon N, et al. Circulating antinuclear and rheumatoid factors in coal miners. A prevalence study in Pennsylvania and West Virginia. Ann Intern Med. 1973;79:807–811.
   PubMed Web of Science ®Google Scholar
• Doll NJ, Stankus RP, Hughes J, et al. Immune complexes and autoantibodies in silicosis. J Allergy Clin Immunol. 1981;68:281–285.
   PubMed Web of Science ®Google Scholar
• Hayashi H, Miura Y, Maeda M, et al. Reductive alteration of the regulatory function of the CD4(+)CD25(+) T cell fraction in silicosis patients. Int J Immunopathol Pharmacol. 2010;23:1099–1109.
   PubMed Web of Science ®Google Scholar
• Rocha-Parise M, Santos LM, Damoiseaux JG, et al. Lymphocyte activation in silica-exposed workers. Int J Hyg Environ Health. 2014;217:586–591.
   PubMed Web of Science ®Google Scholar
• Huang SH, Hubbs AF, Stanley CF, et al. Immunoglobulin responses to experimental silicosis. Toxicol Sci. 2001;59:108–117.
   PubMed Web of Science ®Google Scholar
• Brown JM, Pfau JC, Holian A. Immunoglobulin and lymphocyte responses following silica exposure in New Zealand mixed mice. Inhal Toxicol. 2004;16:133–139.
   PubMed Web of Science ®Google Scholar
• Wu P, Hyodoh F, Hatayama T, et al. Induction of CD69 antigen expression in peripheral blood mononuclear cells on exposure to silica, but not by asbestos/chrysotile-A. Immunol Lett. 2005;98:145–152.
   PubMed Web of Science ®Google Scholar
• Hirai T, Yoshioka Y, Takahashi H, et al. Amorphous silica nanoparticles enhance cross-presentation in murine dendritic cells. Biochem Biophys Res Commun. 2012;427:553–556.
   PubMed Web of Science ®Google Scholar
• Vis B, Hewitt RE, Faria N, et al. Non-functionalized ultrasmall silica nanoparticles directly and size-selectively activate T cells. ACS Nano. 2018;12:10843–10854.
   PubMed Web of Science ®Google Scholar
• Schwartz RH. Historical overview of immunological tolerance. Cold Spring Harb Perspect Biol. 2012;4:a006908.
   PubMed Web of Science ®Google Scholar
• Ueki A, Yamaguchi M, Ueki H, et al. Polyclonal human T-cell activation by silicate in vitro. Immunology. 1994;82:332–335.
   PubMed Web of Science ®Google Scholar
• Khalil N, Churg A, Muller N, et al. Environmental, inhaled and ingested causes of pulmonary fibrosis. Toxicol Pathol. 2007;35:86–96.
   PubMed Web of Science ®Google Scholar
• Samelson LE, Harford JB, Klausner RD. Identification of the components of the murine T cell antigen receptor complex. Cell. 1985;43:223–231.
   PubMed Web of Science ®Google Scholar
• Reth M. Antigen receptor tail clue. Nature. 1989;338:383–384.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Antoniadi G, Liakopoulos V, et al. T-cell zeta chain expression, phosphorylation and degradation and their role in T-cell signal transduction and immune response regulation in health and disease. Curr Signal Transid. 2006;1:191–208.
   Web of Science ®Google Scholar
• Packard TA, Cambier JC. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation. F1000Prime Rep. 2013;5:40.
   PubMedGoogle Scholar
• Chou C, Egawa T. Myc or no Myc, that is the question. EMBO J. 2015;34:1990–1991.
   PubMed Web of Science ®Google Scholar
• Wang R, Dillon CP, Shi LZ, et al. The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity. 2011;35:871–882.
   PubMed Web of Science ®Google Scholar
• Murn J, Mlinaric-Rascan I, Vaigot P, et al. A Myc-regulated transcriptional network controls B-cell fate in response to BCR triggering. BMC Genomics. 2009;10:323.
   PubMed Web of Science ®Google Scholar
• Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today. 1992;13:136–142.
   PubMedGoogle Scholar
• Huse M. The T-cell-receptor signaling network. J Cell Sci. 2009;122:1269–1273.
   PubMed Web of Science ®Google Scholar
• Dalporto J. B cell antigen receptor signaling 101. Mol Immunol. 2004;41:599–613.
   PubMed Web of Science ®Google Scholar
• Lin W, Huang YW, Zhou XD, et al. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006;217:252–259.
   PubMed Web of Science ®Google Scholar
• Badding MA, Stefaniak AB, Fix NR, et al. Cytotoxicity and characterization of particles collected from an indium-tin oxide production facility. J Toxicol Environ Health A. 2014;77:1193–1209.
   PubMed Web of Science ®Google Scholar
• Vuong NQ, Goegan P, De Rose F, et al. Responses of A549 human lung epithelial cells to cristobalite and alpha-quartz exposures assessed by toxicoproteomics and gene expression analysis. J Appl Toxicol. 2017;37:721–731.
   PubMed Web of Science ®Google Scholar
• Guy CS, Vignali KM, Temirov J, et al. Distinct TCR signaling pathways drive proliferation and cytokine production in T cells. Nat Immunol. 2013;14:262–270.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Pissas G, Antoniadi G, et al. Indoleamine 2,3dioxygenase downregulates Tcell receptor complex zetachain and cMyc, and reduces proliferation, lactate dehydrogenase levels and mitochondrial glutaminase in human Tcells. Mol Med Rep. 2016;13:925–932.
   PubMed Web of Science ®Google Scholar
• Pascual J. The pharmacokinetics of everolimus in de novo kidney transplant patients receiving tacrolimus: an analysis from the randomized ASSET study. Ann Transplant. 2014;19:337–345.
   PubMed Web of Science ®Google Scholar
• Wicker LS, Boltz RC, Jr., Matt V, et al. Suppression of B cell activation by cyclosporin A, FK506 and rapamycin. Eur J Immunol. 1990;20:2277–2283.
   PubMed Web of Science ®Google Scholar
• Donahue AC, Fruman DA. Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation. J Immunol. 2003;170:5851–5860.
   PubMed Web of Science ®Google Scholar
• Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008;9:847–856.
   PubMed Web of Science ®Google Scholar
• Hari A, Zhang Y, Tu Z, et al. Activation of NLRP3 inflammasome by crystalline structures via cell surface contact. Sci Rep. 2014;4:7281.
   PubMed Web of Science ®Google Scholar
• Ng G, Sharma K, Ward SM, et al. Receptor-independent, direct membrane binding leads to cell-surface lipid sorting and Syk kinase activation in dendritic cells. Immunity. 2008;29:807–818.
   PubMed Web of Science ®Google Scholar
• Eleftheriadis T, Pissas G, Sounidaki M, et al. Urate crystals directly activate the T-cell receptor complex and induce T-cell proliferation. Biomed Rep. 2017;7:365–369.
   PubMed Web of Science ®Google Scholar
• Flach TL, Ng G, Hari A, et al. Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity. Nat Med. 2011;17:479–487.
   PubMed Web of Science ®Google Scholar
• Corr EM, Cunningham CC, Dunne A. Cholesterol crystals activate Syk and PI3 kinase in human macrophages and dendritic cells. Atherosclerosis. 2016;251:197–205.
   PubMed Web of Science ®Google Scholar
• Nolan RP, Langer AM, Harington JS, et al. Quartz hemolysis as related to its surface functionalities. Environ Res. 1981;26:503–520.
   PubMed Web of Science ®Google Scholar
• Westerhausen C, Strobl FG, Herrmann R, et al. Chemical and mechanical impact of silica nanoparticles on the phase transition behaviour of phospholipid membranes in theory and experiment. Biophys J. 2012;102:1032–1038.
   PubMed Web of Science ®Google Scholar
• Kettiger H, Québatte G, Perrone B, et al. Interactions between silica nanoparticles and phospholipid membranes. Biochim Biophy Acta Biomembr. 2016;1858:2163–2170.
   PubMed Web of Science ®Google Scholar
• Shinto H, Fukasawa T, Yoshisue K, et al. Cell membrane disruption induced by amorphous silica nanoparticles in erythrocytes, lymphocytes, malignant melanocytes, and macrophages. Adv Powder Technol. 2014;25:1872–1881.
   Web of Science ®Google Scholar